Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.
暂无分享,去创建一个
Peter E Wright | H Jane Dyson | H. Dyson | P. Wright | M. Martinez-Yamout | Maria A Martinez-Yamout | Chul Won Lee | Peter E. Wright
[1] H. Jane Dyson,et al. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein , 2009, Proceedings of the National Academy of Sciences.
[2] M. Scheffner,et al. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression , 1993, Molecular and cellular biology.
[3] A. Fersht,et al. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53 , 2007, Proceedings of the National Academy of Sciences.
[4] S. Grzesiek,et al. Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein , 1992 .
[5] H. Sheppard,et al. Analysis of the Steroid Receptor Coactivator 1 (SRC1)-CREB Binding Protein Interaction Interface and Its Importance for the Function of SRC1 , 2001, Molecular and Cellular Biology.
[6] Maria Miller,et al. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. , 2009, Structure.
[7] S. Berger,et al. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity , 1997, Oncogene.
[8] L. Kay,et al. Latent and active p53 are identical in conformation , 2001, Nature Structural Biology.
[9] Cheng Liu,et al. Crystal structure of IRF-3 in complex with CBP. , 2005, Structure.
[10] A. Bax,et al. Measurement of Two- and Three-Bond Proton to Methyl-Carbon J Couplings in Proteins Uniformly Enriched with 13C , 1993 .
[11] Y. Sung,et al. Transactivation Ability of p53 Transcriptional Activation Domain Is Directly Related to the Binding Affinity to TATA-binding Protein (*) , 1995, The Journal of Biological Chemistry.
[12] F. Kashanchi,et al. Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.
[13] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[14] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[15] Wei Gu,et al. p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.
[16] E. Fraenkel,et al. A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies. , 2001, Molecular cell.
[17] Johannes Buchner,et al. The N-terminal domain of p53 is natively unfolded. , 2003, Journal of molecular biology.
[18] A. Fersht,et al. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain , 2008, Proceedings of the National Academy of Sciences.
[19] H. Jane Dyson,et al. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2 , 2009, Proceedings of the National Academy of Sciences.
[20] D. Livingston,et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. , 1998, Molecular cell.
[21] Wei Xu,et al. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators , 2002, Nature.
[22] H. Gronemeyer,et al. The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and ‐independent pathways , 1998, The EMBO journal.
[23] Bruce A. Johnson,et al. NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.
[24] D. Meek,et al. Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 , 1999, The EMBO journal.
[25] K. Sakaguchi,et al. Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.
[26] Janice Bramham,et al. Structural Diversity in p160/CREB-binding Protein Coactivator Complexes* , 2006, Journal of Biological Chemistry.
[27] J. Momand,et al. Solution conformation of an essential region of the p53 transactivation domain. , 1997, Folding & design.
[28] T. Hupp,et al. Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300 , 2001, EMBO reports.
[29] S. Grzesiek,et al. Multiple-Quantum Line Narrowing for Measurement of H.alpha.-H.beta. J Couplings in Isotopically Enriched Proteins , 1995 .
[30] R. Goodman,et al. CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.
[31] D. Peet,et al. Defining the Role for XAP2 in Stabilization of the Dioxin Receptor* , 2003, Journal of Biological Chemistry.
[32] Xinbin Chen,et al. Identification of a Novel p53 Functional Domain That Is Necessary for Mediating Apoptosis* , 1998, The Journal of Biological Chemistry.
[33] D. Livingston,et al. Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.
[34] H. Giebler,et al. Binding of p53 to the KIX Domain of CREB Binding Protein , 1999, The Journal of Biological Chemistry.
[35] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[36] M. Wittekind,et al. HNCACB, a High-Sensitivity 3D NMR Experiment to Correlate Amide-Proton and Nitrogen Resonances with the Alpha- and Beta-Carbon Resonances in Proteins , 1993 .
[37] A. Bax,et al. Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.
[38] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.
[39] G. Wahl,et al. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.
[40] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.
[41] Jill A. Livengood,et al. p53 Transcriptional Activity Is Mediated through the SRC1-interacting Domain of CBP/p300* , 2002, The Journal of Biological Chemistry.
[42] D. Case,et al. Molecular Dynamics Simulations of Nucleic Acids with a Generalized Born Solvation Model , 2000 .
[43] K. Gardner,et al. Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.
[44] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[45] A. Fersht,et al. Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.
[46] G. Marius Clore,et al. 1H1H correlation via isotropic mixing of 13C magnetization, a new three-dimensional approach for assigning 1H and 13C spectra of 13C-enriched proteins , 1990 .
[47] Toshiaki Hara,et al. Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. , 2006, Molecular cell.
[48] G. Wahl,et al. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. , 2006, Cancer cell.
[49] C. Glass,et al. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. , 1998, Genes & development.
[50] Sung-Hun Bae,et al. NMR relaxation study of the complex formed between CBP and the activation domain of the nuclear hormone receptor coactivator ACTR. , 2008, Biochemistry.
[51] P. Wright,et al. Packing, specificity, and mutability at the binding interface between the p160 coactivator and CREB‐binding protein , 2004, Protein science : a publication of the Protein Society.
[52] Torsten Herrmann,et al. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. , 2002, Journal of molecular biology.
[53] H. Dyson,et al. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. , 2009, Biochemistry.
[54] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[55] U. Moll,et al. The MDM2-p53 interaction. , 2003, Molecular cancer research : MCR.
[56] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[57] Kyou-Hoon Han,et al. Local Structural Elements in the Mostly Unstructured Transcriptional Activation Domain of Human p53* , 2000, The Journal of Biological Chemistry.
[58] T. Hupp,et al. The Proline Repeat Domain of p53 Binds Directly to the Transcriptional Coactivator p300 and Allosterically Controls DNA-Dependent Acetylation of p53 , 2003, Molecular and Cellular Biology.
[59] Thierry Soussi,et al. Assessing TP53 status in human tumours to evaluate clinical outcome , 2001, Nature Reviews Cancer.
[60] Pamela D Vise,et al. Identifying long‐range structure in the intrinsically unstructured transactivation domain of p53 , 2007, Proteins.
[61] S. Berger,et al. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. , 1997, Cancer research.
[62] Wei Gu,et al. Synergistic activation of transcription by CBP and p53 , 1997, Nature.
[63] K Wüthrich,et al. Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints , 1991, Journal of biomolecular NMR.
[64] R. Tjian,et al. Repression of p53-mediated transcription by MDM2: a dual mechanism. , 1997, Genes & development.
[65] C. Arrowsmith,et al. Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[66] C. Glass,et al. Molecular determinants of nuclear receptor-corepressor interaction. , 1999, Genes & development.
[67] R. Wadgaonkar,et al. Murine Double Minute (MDM2) Blocks p53-coactivator Interaction, a New Mechanism for Inhibition of p53-dependent Gene Expression* , 1999, The Journal of Biological Chemistry.
[68] P. Tompa,et al. Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. , 2008, Trends in biochemical sciences.
[69] P. Tompa,et al. Malleable machines take shape in eukaryotic transcriptional regulation. , 2008, Nature chemical biology.
[70] A. Bax,et al. An alternative 3D NMR technique for correlating backbone 15N with side chain Hβ resonances in larger proteins , 1991 .